Skip Navigation
Skip to contents

KMJ : Kosin Medical Journal

OPEN ACCESS
SEARCH
Search

Best practices

Page Path
HOME > About > Best practices
About

Table of Contents

As an open access journal, the Kosin Medical Journal (KMJ) will follow the Principles of Transparency and Best Practice in Scholarly Publishing (https://doaj.org/bestpractice) developed by the Committee on Publication Ethics (COPE), the Directory of Open Access Journals (DOAJ), the Open Access Scholarly Publishers Association (OASPA), and the World Association of Medical Editors (WAME).
1) The URL of official journal web site is https://www.kosinmedj.org. The KMJ team endeavors to make the website as user-friendly and accessible as possible. Care has been taken to ensure the presentation of materials meets high ethical and professional standards. It does not contain any misleading information nor any attempt to mimic another journal/publisher’s site.
2) Aims and scope: The Kosin Medical Journal (Kosin Med J, KMJ, pISSN 2005-9531, eISSN 2586-7024, https://www.kosinmedj.org), the official publication of the Kosin University College of Medicine, is a peer-reviewed and open access journal of research in all medical fields, including medicine, medical science, medical ethics, and medical education. Its regional focus is Korea, but it welcomes submissions from researchers all over the world.
The KMJ aims to communicate new medical information to medical personnel and to facilitate the development of medicine, medical science, medical ethics, and medical education and the propagation of medical knowledge by publishing high-quality, evidence-based articles.
The KMJ publishes editorials, review articles, original articles, and case reports. All manuscripts should be creative, informative, and helpful for the diagnosis and treatment of medical diseases and for the communication of valuable information about all fields of medicine, medical science, medical ethics, and medical education.
3) Authorship: The KMJ accepts authorship criteria recommended by the ICMJE (http://www.icmje.org/recommendations/browse/roles-and-responsibilities/defining-the-role-of-authors-and-contributors.html) and the Good Publication Practice Guidelines by the Korean Association of Medical Journal Editors (KAMJE, 2019, http://kamje.or.kr).
Each author is expected to have made a substantial contribution to the conception or design of the work; the acquisition, analysis, or interpretation of data; the creation of new software used in the work; or have drafted the work or substantively revised it; AND to have approved the submitted version (and any substantially modified version that involves the author’s contributions to the study); AND to have agreed both to be personally accountable for the author’s own contributions and to ensuring that questions related to the accuracy or integrity of any part of the work, even ones in which the author was not personally involved, are appropriately investigated, resolved, and the resolution documented in the literature.
Those who do not meet these criteria should be acknowledged as contributors instead of authors. The corresponding author is responsible for completing this information at submission, and all authors are expected to review, discuss, and agree to their individual contribution ahead of this time.
When a large, multicenter group has conducted the work, the group should identify the individuals who accept direct responsibility for the manuscript. When submitting a manuscript authored by a group, the corresponding author should clearly indicate the preferred citation and identify all individual authors as well as the group name. Journals generally list other members of the group in the Acknowledgments. Acquisition of funding, collection of data, or general supervision of the research group alone does not constitute authorship.
The KMJ accepts notice of equal contribution for the first or corresponding authors when the study was clearly performed by co-first or co-corresponding authors.
The KMJ does not allow for authorship corrections after publication unless the editorial staff makes an obvious mistake. Before publication, authorship can be changed if all authors request such a correction.
4) Redundant publication and plagiarism: Redundant publication is defined as “reporting (publishing or attempting to publish) substantially the same work more than once, without attribution of the original source(s).” Characteristics of reports that are substantially similar include the following: (a) “at least one of the authors must be common to all reports (if there are no common authors, it is more likely plagiarism than redundant publication),” (b) “the subjects or study populations are the same or overlapped,” (c) “the methodology is typically identical or nearly so,” and (d) “the results and their interpretation generally vary little, if at all.”
When submitting a manuscript, authors should include a letter informing the editor of any potential overlap with other already published material or material being evaluated for publication, and should also state how the submitted manuscript differs substantially from other materials. If all or part of the patient population was previously reported, this should be mentioned in the Methods and Materials section, with citation of the appropriate reference(s).
Duplication will be checked through a crosscheck (https://app.ithenticate.com) or eTBLAST (https://helioblast.heliotext.com) before publication. If duplicate publication related to the papers of this journal is detected, the manuscript may be rejected, the authors will be announced in the journal, and their institutes will be informed. There will also be penalties for the authors.
The official journal title is the Kosin Medical Journal. The abbreviated title is Kosin Med J and KMJ.
The KMJ has on online submission and peer-review system, which is accessible at https://submit.kosinmedj.org. The KMJ reviews all manuscripts received. The managing editor performs an initial quality check to identify potential issues, such as competing interests, compliance with editorial policies and ethical standards, and financial disclosures. Submissions may be returned to authors for changes or clarifications at this stage. A manuscript is previewed for its format and academic relevancy, and then rejected or sent to 2 or more relevant investigators available to review the contents. The identities of the reviewers will not be revealed to the authors and vice versa (a double-blinded review). The editor selects peer reviewers on the recommendation of the Editorial Board members or using the Board’s specialist database. In addition, and if deemed necessary, a review of the statistical analysis may be requested. Members of the editorial board are permitted to submit articles to the KMJ. These submissions are not given priority over other manuscripts, and Editorial Board Member status has no bearing on editorial consideration. Acceptance or rejection of the manuscript is based on the critiques and recommended decision of the referees. A reviewer may recommend “accept,” “minor revision,” “major revision,” or “reject.” In the event of a discrepancy in the decisions between two referees or between the opinions of the author and reviewer(s), the Editor may send the manuscript to another reviewer for additional comments and a recommendation. The reviewed manuscripts are returned to the corresponding author with comments and recommended revisions. The names and decisions of the reviewers are masked. A final editor's decision on acceptance or rejection for publication is forwarded by the Editorial Office to the corresponding author.
The most common reasons for rejection are topics that are too specific and a target audience that is too limited, insufficient originality, serious scientific flaws, poor quality of illustrations, or absence of a message of importance to readers. Rarity of a disease condition is itself not an acceptable justification for a case report. The peer-review process takes usually two to three weeks after the manuscript submission.
Revisions are usually requested to address criticisms and comments made by reviewers. The revised manuscript should be resubmitted through the KMJ web portal. Failure to resubmit the revised manuscript within 2 months without notice from the corresponding author is regarded as a withdrawal. The corresponding author must indicate clearly any alterations that have been made in response to the reviewer's comments point by point. Acceptable reasons should be given for noncompliance with any recommendation of the reviewers.
This journal is owned by the publisher, the Kosin University College of Medicine (https://www.kucm.ac.kr).
The governing body is the journal's Editorial Board.
The full names and affiliations of the journal’s editors and members of the Journal management team are displayed on the About (Editorial Board) tab of the Journal homepage, and the contact information for the Editor and editorial office is on the About (Contact Us) tab.
The copyright for all published materials is held by the Kosin University College of Medicine. All authors should agree to the copyright transfer during the submission process.
The KMJ is an open access journal. Articles are distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Manuscripts that have accepted will be charged KRW 300,000. There is no surcharge for color figures.
The editorial board of KMJ carefully examines all submitted manuscripts to determine whether the authors have abided by the ethical guidelines of the ICMJE and COPE. Published articles may include statements of conflict of interest, institutional review board, informed consent, and human/animal rights.
When the KMJ encounters a suspected case of research and publication misconduct, such as a redundant (duplicate) publication, plagiarism, fabricated data, changes in authorship, undisclosed conflicts of interest, an ethical problem with the submitted manuscript, a reviewer who has appropriated an author’s idea or data, complaints against editors, and other issues, the resolving process will follow the COPE flowchart at http://publicationethics.org/resources/flowcharts. The editorial board of the KMJ will discuss the suspected cases and reach a decision. The KMJ will not hesitate to publish errata, corrigenda, clarifications, retractions, and apologies when needed.
KMJ follows the Guideline on Good Publication of COPE (https://publicationethics.org), Recommendations of International Committee of Medical Journal Editors (http://www.icmje.org/recommendations), and Good Publication Practice Guidelines for Medical Journals of Korean Association of Medical Journal Editors (http://kamje.or.kr).
Our publication ethics are displayed on the Instructions for Authors (Ethical Considerations) tab of the Journal homepage.
The KMJ is published quarterly (March 31, June 30, September 30, and December).
The KMJ is an open access journal. Free access to full-text versions of articles in both XML and PDF formats is available immediately upon publication without an embargo period.
Full-text issues of the KMJ are archived using the Korea Citation Index from volume 1, 1985, to the latest issue (https://www.kci.go.kr/kciportal/po/search/poArtiSearList.kci). According to the deposit (self-archiving) policy of Sherpa/Romeo (http://www.sherpa.ac.uk), authors cannot archive pre-prints (i.e., pre-refereed articles), but they can archive post-print (i.e. final draft post-refereeing). Authors can archive the publisher's version as a PDF.
Revenue sources of the journal include the publisher (Kosin University College of Medicine) and author fees.
The KMJ does not accept advertisements.
Journal propagation is through the Journal website and distribution of an introductory pamphlet. Invitations to submit a manuscript typically focus on presenters at conferences, seminars, or workshops if the topic is related to the journal's aims and scope.

KMJ : Kosin Medical Journal